JAMA Editors' Summary

Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Mar 10, 2015
Ask episode
Chapters
Transcript
Episode notes